J Biomed Mater Res. 1989 Dec;23(A3 Suppl):311-9.

Toxic hydrolysis product from a biodegradable foam implant.

·         Batich C,

·         Williams J,

·         King R.

Materials Science and Engineering, University of Florida, Gainesville 32611.

A commercially available mammary implant containing a soft polyester polyurethane foam shell has been examined for possible diamine hydrolysis products. Fourier Transform Infrared (FT-IR) analysis has shown ester and aromatic structures present in the intact foam shell. Vigorous hydrolysis conditions using NaOH have produced a mixture with large amounts of toluene diamine (TDA) present as determined by Gas Chromatography-Mass Spectrometry (GC/MS), and GC/FT-IR. There are numerous clinical reports of the degradation of this implant shell after implantation with incorporation of fragments into phagocytic cells at the implantation site. Recent reports have discussed late pain and other allergic reactions to this implant. Release of the known toxic material, TDA, is consistent with these observations and strongly suggests that an alternative material be used in this application.

PMID: 2613741 [PubMed - indexed for MEDLINE]

Alternative Implants

The information on this website is presented for educational purposes by the Human Adjuvant Disease Corp.